PReS-FINAL-2098: Evaluation of the disease course of Italian children with juvenile idiopathic arthritis treated with etanercept: preliminary results in 313 patients

Por Verazza, S, Consolaro, A, Frisina, A, Conti, G, Rigante, D, Robbiano, C, Alpigiani, MG, Ravelli, A
Publicado em 2013

PReS-FINAL-2176: Declines in levels of disease activity and physical disability in children with juvenile idiopathic arthritis seen in standard clinical care over the last 25 years

Por Consolaro, A, Lanni, S, Minoia, F, Davì, S, Dalprà, S, Schiappapietra, B, Muratore, V, Martini, A, Ravelli, A
Publicado em 2013

PReS-FINAL-2143: Treat-to-target strategy in juvenile idiopathic arthritis: experience in 175 newly-diagnosed patients

Por Negro, G, Consolaro, A, Verazza, S, Bracciolini, G, Rosina, S, Pignataro, R, Civino, A, Martini, A, Ravelli, A
Publicado em 2013

Agreement between objective and subjective definitions of inactive disease, remission and minimal disease activity in juvenile idiopathic arthritis

Por Davì S, Lanni S, Solari N, Magni-Manzoni S, Consolaro A, Schiappapietra B, Pederzoli S, Bracciolini G, Martini A, Ravelli A
Publicado em 2011-09-01

Children with juvenile idiopathic arthritis currently followed in a tertiary care setting have a better psychosocial well-being than healthy peers

Por Bertamino, M, Consolaro, A, Lattanzi, B, Magni-Manzoni, S, Lanni, S, Suffia, C, Dalprà, S, Rosina, S, Martini, A, Ravelli, A
Publicado em 2011

Agreement between objective and subjective definitions of inactive disease, remission and minimal disease activity in juvenile idiopathic arthritis

Por Schiappapietra, B, Consolaro, A, Magni-Manzoni, S, Solari, N, Lanni, S, Davì, S, Pederzoli, S, Bracciolini, G, Martini, A, Ravelli, A
Publicado em 2011

PReS-FINAL-2132: Defining criteria for high disease activity in juvenile idiopathic arthritis: definition and validation of juvenile arthritis disease activity score cutoffs

Por Consolaro, A, Verazza, S, Gallo, MC, Bracciolini, G, Negro, G, Frisina, A, Ruperto, N, Martini, A, Ravelli, A
Publicado em 2013

PReS-FINAL-2028: ANA positivity and a younger age at onset, but not disease category, predict the risk of uveitis in italian children with juvenile idiopathic arthritis

Por Schiappapietra, B, Calandra, S, Gallo, MC, De Marco, R, Muratore, V, Lanni, S, Consolaro, A, Martini, A, Ravelli, A
Publicado em 2013

Comparison of the accuracy of different definitions of clinical remission (CR) and minimal disease activity (MDA) in juvenile idiopathic arthritis (JIA)

Por Davì, S, Consolaro, A, Ferrari, C, Federici, S, Vitale, R, Filocamo, G, Loy, A, Ruperto, N, Martini, A, Ravelli, A
Publicado em 2008

Comparison of physician's, parent's and patient's global ratings made on linear or 21-circle visual analogue scales (VAS) in juvenile idiopathic arthritis (JIA)

Por Dalprà, S, Verazza, S, Ferrari, C, Parodi, A, Davì, S, Schiappapietra, B, Consolaro, A, Filocamo, G, Viola, S, Martini, A, Ravelli, A
Publicado em 2008

Do parent's global rating of well-being and disease activity of children with juvenile idiopathic arthritis yield different information?

Por Ullmann, N, Consolaro, A, Filocamo, G, Verazza, S, Dalprà, S, Ferrari, C, Caorsi, R, Viola, S, Visconti, C, Martini, A, Ravelli, A
Publicado em 2008

Development and initial validation of a new functional ability tool for juvenile dermatomyositis

Por Demirkaya E, Madeo A, Rao AP, Malattia C, Consolaro A, Varnier GC, Lazarevic D, Civino A, Martini A, Ravelli A
Publicado em 2011-09-01

A new approach to defining inactive disease, minimal disease activity and parent- and child-acceptable symptom state in juvenile idiopathic arthritis

Por Consolaro, A, Filocamo, G, Bertamino, M, Palmisani, E, Bracciolini, G, Suffia, C, Muratore, V, Ruperto, N, Martini, A, Ravelli, A
Publicado em 2011

Development and initial validation of a new functional ability tool for juvenile dermatomyositis

Por Varnier, GC, Consolaro, A, Malattia, C, Rao, AP, Madeo, A, Demirkaya, E, Lazarevic, D, Civino, A, Martini, A, Ravelli, A
Publicado em 2011

PReS-FINAL-2010: Predictive value of whole-body MRI in juvenile dermatomyositis

Por Malattia, C, Madeo, A, Dellepiane, M, Pistorio, A, Damasio, MB, Viola, S, Pederzoli, S, Beltramo, A, Beleva, D, Consolaro, A, Martini, A
Publicado em 2013

PReS-FINAL-2193: Assessment of construct validity of new measures of global disease activity, physical function and quality of life in children with juvenile dermatomyositis

Por Ferrari, C, Varnier, GC, Consolaro, A, Marafon, D, Pilkington, C, Maillard, S, Jelusic-Drazic, M, Civino, A, Martini, A, Ravelli, A
Publicado em 2013

Use of the JADAS criteria to assess efficacy of canakinumab in patients with SJIA – an analysis of 12-week pooled data

Por Ravelli, A, Brunner, HI, Ruperto, N, Quartier, P, Consolaro, A, Wulffraat, N, Lheritier, K, Gaillez, C, Martini, A, Lovell, DJ
Publicado em 2014

Maintenance of efficacy of canakinumab in SJIA at the individual patient level in a 12-week pooled dataset

Por Ravelli, A, Brunner, HI, Ruperto, N, Quartier, P, Consolaro, A, Wulffraat, N, Lheritier, K, Gaillez, C, Martini, A, Lovell, DJ
Publicado em 2014

PReS-FINAL-2011: Preliminary validation of a new hybrid measure of muscle strength for juvenile dermatomyositis

Por Marafon, D, Consolaro, A, Ferrari, C, Dalprà, S, Madeo, A, Providenti, A, Malattia, C, Ruperto, N, Civino, A, Martini, A, Ravelli, A
Publicado em 2013

PReS-FINAL-2012: Introducing a new approach to clinical care of juvenile dermatomyositis: the juvenile dermatomyositis multidimensional assessment report

Por Varnier, GC, Ferrari, C, Consolaro, A, Marafon, D, Pilkington, C, Maillard, S, Jelusic Drazic, M, Dalpra', S, Civino, A, Martini, A, Ravelli, A
Publicado em 2013